|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.93 CAD | -2.66% |
|
+2.45% | -62.44% |
BriaCell Therapeutics Corp. reported earnings results for the first quarter ended October 31, 2023. For the first quarter, the company reported net income was USD 6 million compared to net loss of USD 1.11 million a year ago.
Basic earnings per share from continuing operations was USD 0.38 compared to basic loss per share from continuing operations of USD 0.07 a year ago. Diluted loss per share from continuing operations was USD 0.5 compared to USD 0.07 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -62.44% | 34.21M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
BRIACELL THERAPEUTICS CORP. 
